CD40 Ligand: A neo-inflammatory molecule in vascular diseases

Immunobiology

Volumn 217, Issue 5, 2012, Pages 521-532

  Hassan, Ghada S ^a   Merhi, Yahye ^b   Mourad, Walid ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Athero thrombosis; Atherosclerosis; CD40; CD40 Ligand; Restenosis; Vascular cells; IIb 3, 5 1, and M 2 integrins

Indexed keywords

ALPHAIIBBETA3 INTEGRIN; ALPHAVBETA1 INTEGRIN; CD11B ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; GELATINASE A; GELATINASE B; GLYCOPROTEIN; INTERSTITIAL COLLAGENASE; STROMELYSIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANGIOGENESIS; ATHEROSCLEROSIS; CELL TYPE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HUMAN; HUMORAL IMMUNITY; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE; THYMUS;

EID: 84858783225     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.03.010     Document Type: Review

References (96)

1. Andre P., Nannizzi-Alaimo L., Prasad S.K., Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002, 106:896-899.
2. Andre P., Prasad K.S., Denis C.V., He M., Papalia J.M., Hynes R.O., Phillips D.R., Wagner D.D. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat. Med. 2002, 8:247-252.
3. Aukrust P., Muller F., Ueland T., Berget T., Aaser E., Brunsvig A., Solum N.O., Forfang K., Froland S.S., Gullestad L. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999, 100:614-620.
4. Barillari G., Albonici L., Incerpi S., Bogetto L., Pistritto G., Volpi A., Ensoli B., Manzari V. Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function. Atherosclerosis 2001, 154:377-385.
5. Blystone S.D., Graham I.L., Lindberg F.P., Brown E.J. Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1. J. Cell Biol. 1994, 127:1129-1137.
6. Breithaupt-Faloppa A.C., Kleinheinz J., Crivello O. Endothelial cell reaction on a biological material. J. Biomed. Mater. Res. B: Appl. Biomater. 2006, 76:49-55.
7. Browatzki M., Pfeiffer C.A., Schmidt J., Kranzhofer R. Endothelin-1 induces functionally active CD40 protein via nuclear factor-kappaB in human vascular smooth muscle cells. Eur. J. Med. Res. 2007, 12:129-133.
8. Bruemmer D., Riggers U., Holzmeister J., Grill M., Lippek F., Settmacher U., Regitz-Zagrosek V., Fleck E., Graf K. Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am. J. Cardiol. 2001, 87:21-27.
9. Cascone I., Napione L., Maniero F., Serini G., Bussolino F. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J. Cell Biol. 2005, 170:993-1004.
10. Chai H., Aghaie K., Zhou W. Soluble CD40 ligand induces human coronary artery smooth muscle cells proliferation and migration. Surgery 2009, 146:5-11.
11. Chakrabarti S., Varghese S., Vitseva O., Tanriverdi K., Freedman J.E. CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2428-2434.
12. Chen C., Chai H., Wang X., Jiang J., Jamaluddin M.S., Liao D., Zhang Y., Wang H., Bharadwaj U., Zhang S., Li M., Lin P., Yao Q. Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood 2008, 112:3205-3216.
13. Cipollone F., Ferri C., Desideri G., Paloscia L., Materazzo G., Mascellanti M., Fazia M., Iezzi A., Cuccurullo C., Pini B., Bucci M., Santucci A., Cuccurullo F., Mezzetti A. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003, 108:2776-2782.
14. Danese S., de la Motte C., Reyes B.M., Sans M., Levine A.D., Fiocchi C. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J. Immunol. 2004, 172:2011-2015.
15. Danese S., Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit. Rev. Immunol. 2005, 25:103-121.
16. De Caterina R., Massaro M., Scoditti E., Annunziata Carluccio M. Pharmacological modulation of vascular inflammation in atherothrombosis. Ann. N. Y. Acad. Sci. 2010, 1207:23-31.
17. Deregibus M.C., Buttiglieri S., Russo S., Bussolati B., Camussi G. CD40-dependent activation of phosphatidylinositol 3-kinase/akt pathway mediates endothelial cell survival and in vitro angiogenesis. J. Biol. Chem. 2003, 278:18008-18014.
18. Donners M.M., Beckers L., Lievens D., Munnix I., Heemskerk J., Janssen B.J., Wijnands E., Cleutjens J., Zernecke A., Weber C., Ahonen C.L., Benbow U., Newby A.C., Noelle R.J., Daemen M.J., Lutgens E. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood 2008, 111:4596-4604.
19. Garlichs C.D., Eskafi S., Raaz D., Schmidt A., Ludwig J., Herrmann M., Klinghammer L., Daniel W.G., Schmeisser A. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 2001, 86:649-655.
20. Garlichs C.D., John S., Schmeisser A., Eskafi S., Stumpf C., Karl M., Goppelt-Struebe M., Schmieder R., Daniel W.G. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 2001, 104:2395-2400.
21. Geraldes P., Gagnon S., Hadjadj S., Merhi Y., Sirois M.G., Cloutier I., Tanguay J.F. Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERalpha-mediated pathway. Cardiovasc. Res. 2006, 71:566-573.
22. Gui P., Wu X., Ling S., Stotz S.C., Winkfein R.J., Wilson E., Davis G.E., Braun A.P., Zamponi G.W., Davis M.J. Integrin receptor activation triggers converging regulation of Cav1.2 calcium channels by c-Src and protein kinase A pathways. J. Biol. Chem. 2006, 281:14015-14025.
23. Hakkinen T., Karkola K., Yla-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch. 2000, 437:396-405.
24. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
25. Henn V., Steinbach S., Buchner K., Presek P., Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001, 98:1047-1054.
26. Hollenbaugh D., Mischel Petty N., Edwards C.P., Simon J.C., Denfeld R.W., Kiener P.A., Aruffo A. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 1995, 182:33-40.
27. Hristov M., Gumbel D., Lutgens E., Zernecke A., Weber C. Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury. Circulation 2010, 121:315-324.
28. Humphries M.J. Integrin structure. Biochem. Soc. Trans. 2000, 28:311-339.
29. Humphries M.J. Integrin activation: the link between ligand binding and signal transduction. Curr. Opin. Cell Biol. 1996, 8:632-640.
30. Inwald D.P., McDowall A., Peters M.J., Callard R.E., Klein N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ. Res. 2003, 92:1041-1048.
31. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., Pober J.S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:4342-4346.
32. Kirk A.D., Morrell C.N., Baldwin W.M. Platelets influence vascularized organ transplants from start to finish. Am. J. Transplant. 2009, 9:14-22.
33. Kotowicz K., Dixon G.L., Klein N.J., Peters M.J., Callard R.E. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology 2000, 100:441-448.
34. L'Allier P.L., Tardif J.C., Gregoire J., Joyal M., Lesperance J., Fortier A., Guertin M.C. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis. Can. J. Cardiol. 2005, 21:495-500.
35. Leveille C., Bouillon M., Guo W., Bolduc J., Sharif-Askari E., El-Fakhry Y., Reyes-Moreno C., Lapointe R., Merhi Y., Wilkins J.A., Mourad W. CD40 ligand binds to {alpha}5beta1 integrin and triggers cell signaling. J. Biol. Chem. 2007, 282:5143-5151.
36. Li D., Liu L., Chen H., Sawamura T., Mehta J.L. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23:816-821.
37. Li G., Sanders J.M., Bevard M.H., Sun Z., Chumley J.W., Galkina E.V., Ley K., Sarembock I.J. CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am. J. Pathol. 2008, 172:1141-1152.
38. Libby P. Multiple mechanisms of thrombosis complicating atherosclerotic plaques. Clin. Cardiol. 2000, 23(Suppl. 6). VI-3-7.
39. Lievens D., Zernecke A., Seijkens T., Soehnlein O., Beckers L., Munnix I.C., Wijnands E., Goossens P., van Kruchten R., Thevissen L., Boon L., Flavell R.A., Noelle R.J., Gerdes N., Biessen E.A., Daemen M.J., Heemskerk J.W., Weber C., Lutgens E. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010, 116:4317-4327.
40. Loike J.D., Silverstein R., Cao L., Solomon L., Weitz J., Haber E., Matsueda G.R., Bernatowicz M.S., Silverstein S.C. Activated platelets form protected zones of adhesion on fibrinogen and fibronectin-coated surfaces. J. Cell Biol. 1993, 121:945-955.
41. Lutgens E., Cleutjens K.B., Heeneman S., Koteliansky V.E., Burkly L.C., Daemen M.J. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:7464-7469.
42. Lutgens E., Daemen M.J. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc. Med. 2002, 12:27-32.
43. Lutgens E., Gorelik L., Daemen M.J., de Muinck E.D., Grewal I.S., Koteliansky V.E., Flavell R.A. Requirement for CD154 in the progression of atherosclerosis. Nat. Med. 1999, 5:1313-1316.
44. Lutgens E., Lievens D., Beckers L., Donners M., Daemen M. CD40 and its ligand in atherosclerosis. Trends Cardiovasc. Med. 2007, 17:118-123.
45. Lutgens E., Lievens D., Beckers L., Wijnands E., Soehnlein O., Zernecke A., Seijkens T., Engel D., Cleutjens J., Keller A.M., Naik S.H., Boon L., Oufella H.A., Mallat Z., Ahonen C.L., Noelle R.J., de Winther M.P., Daemen M.J., Biessen E.A., Weber C. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J. Exp. Med. 2010, 207:391-404.
46. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997, 96:396-399.
47. Mach F., Schonbeck U., Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis?. Atherosclerosis 1998, 137(Suppl.):S89-S95.
48. Mach F., Schonbeck U., Sukhova G., Bourcier T., Bonnefoy J., Pober J., Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1931-1936.
49. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200-203.
50. Mathur R.K., Awasthi A., Wadhone P., Ramanamurthy B., Saha B. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat. Med. 2004, 10:540-544.
51. May A.E., Kalsch T., Massberg S., Herouy Y., Schmidt R., Gawaz M. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 2002, 106:2111-2117.
52. Melter M., Reinders M.E., Sho M., Pal S., Geehan C., Denton M.D., Mukhopadhyay D., Briscoe D.M. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 2000, 96:3801-3808.
53. Miller D.L., Yaron R., Yellin M.J. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J. Leukoc. Biol. 1998, 63:373-379.
54. Mukundan L., Milhorn D.M., Matta B., Suttles J. CD40-mediated activation of vascular smooth muscle cell chemokine production through a Src-initiated, MAPK-dependent pathway. Cell Signal. 2004, 16:375-384.
55. Mulhaupt F., Matter C.M., Kwak B.R., Pelli G., Veillard N.R., Burger F., Graber P., Luscher T.F., Mach F. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc. Res. 2003, 59:755-766.
56. Murugaiyan G., Martin S., Saha B. CD40-induced countercurrent conduits for tumor escape or elimination?. Trends Immunol. 2007, 28:467-473.
57. Omari K.M., Chui R., Dorovini-Zis K. Induction of beta-chemokine secretion by human brain microvessel endothelial cells via CD40/CD40L interactions. J. Neuroimmunol. 2004, 146:203-208.
58. Orecchia A., Lacal P.M., Schietroma C., Morea V., Zambruno G., Failla C.M. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin. J. Cell Sci. 2003, 116:3479-3489.
59. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 2008, 54:24-38.
60. Phipps R.P. CD40: lord of the endothelial cell. Blood 2008, 112:3531-3532.
61. Pluvinet R., Olivar R., Krupinski J., Herrero-Fresneda I., Luque A., Torras J., Cruzado J.M., Grinyo J.M., Sumoy L., Aran J.M. CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling. Blood 2008, 112:3624-3637.
62. Prasad K.S., Andre P., He M., Bao M., Manganello J., Phillips D.R. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:12367-12371.
63. Rahman S., Aitken A., Flynn G., Formstone C., Savidge G.F. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation. Biochem. J. 1998, 335(Pt 2):247-257.
64. Remskar M., Li H., Chyu K.Y., Shah P.K., Cercek B. Absence of CD40 signaling is associated with an increase in intimal thickening after arterial injury. Circ. Res. 2001, 88:390-394.
65. Reyes-Moreno C., Girouard J., Lapointe R., Darveau A., Mourad W. CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J. Biol. Chem. 2004, 279:7799-7806.
66. Reyes-Moreno C., Sharif-Askari E., Girouard J., Leveille C., Jundi M., Akoum A., Lapointe R., Darveau A., Mourad W. Requirement of oxidation-dependent CD40 homodimers for CD154/CD40 bidirectional signaling. J. Biol. Chem. 2007, 282:19473-19480.
67. Rub A., Dey R., Jadhav M., Kamat R., Chakkaramakkil S., Majumdar S., Mukhopadhyaya R., Saha B. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat. Immunol. 2009, 10:273-280.
68. Sakurai K., Cominacini L., Garbin U., Fratta Pasini A., Sasaki N., Takuwa Y., Masaki T., Sawamura T. Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin-like oxidized LDL receptor (LOX-1). J. Cardiovasc. Pharmacol. 2004, 44(Suppl. 1):S173-S180.
69. Sandilands G.P., McCrae J., Hill K., Perry M., Baxter D. Major histocompatibility complex class II (DR) antigen and costimulatory molecules on in vitro and in vivo activated human polymorphonuclear neutrophils. Immunology 2006, 119:562-571.
70. Sanguigni V., Ferro D., Pignatelli P., Del Ben M., Nadia T., Saliola M., Sorge R., Violi F. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 2005, 45:35-42.
71. Schonbeck U., Gerdes N., Varo N., Reynolds R.S., Horton D.B., Bavendiek U., Robbie L., Ganz P., Kinlay S., Libby P. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 2002, 106:2888-2893.
72. Schonbeck U., Libby P. CD40 signaling and plaque instability. Circ. Res. 2001, 89:1092-1103.
73. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 2001, 58:4-43.
74. Schonbeck U., Mach F., Bonnefoy J.Y., Loppnow H., Flad H.D., Libby P. Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta. J. Biol. Chem. 1997, 272:19569-19574.
75. Schonbeck U., Mach F., Sukhova G., Murphy C., Bonnefoy J., Fabunmi R., Libby P. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?. J. Circ. Res. 1997, 81:448-454.
76. Schonbeck U., Mach F., Sukhova G.K., Atkinson E., Levesque E., Herman M., Graber P., Basset P., Libby P. Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo. J. Exp. Med. 1999, 189:843-853.
77. Schonbeck U., Mach F., Sukhova G.K., Herman M., Graber P., Kehry M.R., Libby P. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am. J. Pathol. 2000, 156:7-14.
78. Schonbeck U., Sukhova G.K., Shimizu K., Mach F., Libby P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:7458-7463.
79. Seales E.C., Shaikh F.M., Woodard-Grice A.V., Aggarwal P., McBrayer A.C., Hennessy K.M., Bellis S.L. A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation. J. Biol. Chem. 2005, 280:37610-37615.
80. Souza H.P., Frediani D., Cobra A.L., Moretti A.I., Jurado M.C., Fernandes T.R., Cardounel A.J., Zweier J.L., Tostes R.C. Angiotensin II modulates CD40 expression in vascular smooth muscle cells. Clin. Sci. (Lond.) 2009, 116:423-431.
81. Thienel U., Loike J., Yellin M.J. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets. Cell. Immunol. 1999, 198:87-95.
82. Turker S., Guneri S., Akdeniz B., Ozcan M.A., Baris N., Badak O., Kirimli O., Yuksel F. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease. Am. J. Cardiol. 2006, 97:198-202.
83. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 2000, 67:2-17.
84. Vowinkel T., Wood K.C., Stokes K.Y., Russell J., Krieglstein C.F., Granger D.N. Differential expression and regulation of murine CD40 in regional vascular beds. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H631-H639.
85. Wagner A.H., Gebauer M., Pollok-Kopp B., Hecker M. Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood 2002, 99:520-525.
86. Wagner A.H., Guldenzoph B., Lienenluke B., Hecker M. CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction. Arterioscler. Thromb. Vasc. Biol. 2004, 24:715-720.
87. Wang J., Milner R. Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling. J. Neurochem. 2006, 96:148-159.
88. Wexberg P., Jordanova N., Strehblow C., Syeda B., Meyer B., Charvat S., Zorn G., Scheinig D., Wojta J., Huber K., Glogar D., Gyongyosi M. Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation. Thromb. Haemost. 2008, 99:739-748.
89. Wu M., Li Y.G. The expression of CD40-CD40L and activities of matrix metalloproteinases in atherosclerotic rats. Mol. Cell. Biochem. 2006, 282:141-146.
90. Xu F., Ji J., Li L., Chen R., Hu W. Activation of adventitial fibroblasts contributes to the early development of atherosclerosis: a novel hypothesis that complements the "Response-to-Injury Hypothesis" and the "Inflammation Hypothesis" Med. Hypotheses 2007, 69:908-912.
91. Yacoub D., Hachem A., Theoret J.F., Gillis M.A., Mourad W., Merhi Y. Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2424-2433.
92. Yan J.C., Ding S., Liang Y., Ma G.S., Zhu J., Feng Y., Luo D. Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention. Acta Pharmacol. Sin. 2007, 28:339-343.
93. Yellin M.J., Brett J., Baum D., Matsushima A., Szabolcs M., Stern D., Chess L. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 1995, 182:1857-1864.
94. Yellin M.J., Winikoff S., Fortune S.M., Baum D., Crow M.K., Lederman S., Chess L. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J. Leukoc. Biol. 1995, 58:209-216.
95. Zhou L., Stordeur P., de Lavareille A., Thielemans K., Capel P., Goldman M., Pradier O. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity. Thromb. Haemost. 1998, 79:1025-1028.
96. Zirlik A., Maier C., Gerdes N., MacFarlane L., Soosairajah J., Bavendiek U., Ahrens I., Ernst S., Bassler N., Missiou A., Patko Z., Aikawa M., Schonbeck U., Bode C., Libby P., Peter K. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007, 115:1571-1580.